Cargando…
IPA-3 Inhibits the Growth of Liver Cancer Cells By Suppressing PAK1 and NF-κB Activation
Hepatocellular carcinoma (HCC) is one of the major malignancies worldwide and is associated with poor prognosis due to the high incidences of metastasis and tumor recurrence. Our previous study showed that overexpression of p21-activated protein kinase 1 (PAK1) is frequently observed in HCC and is a...
Autores principales: | Wong, Leo Lap-Yan, Lam, Ian Pak-Yan, Wong, Tracy Yuk-Nar, Lai, Wai-Lung, Liu, Heong-Fai, Yeung, Lam-Lung, Ching, Yick-Pang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716906/ https://www.ncbi.nlm.nih.gov/pubmed/23894351 http://dx.doi.org/10.1371/journal.pone.0068843 |
Ejemplares similares
-
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
por: Lam, Yuk-Fai, et al.
Publicado: (2011) -
The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes
por: Singhal, Ruchi, et al.
Publicado: (2012) -
IPA 2009 International Meeting (IPA Rio)
Publicado: (2009) -
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
por: Lam, Yuk-Fai, et al.
Publicado: (2017) -
Group I PAK Inhibitor IPA-3 Induces Cell Death and Affects Cell Adhesivity to Fibronectin in Human Hematopoietic Cells
por: Kuželová, Kateřina, et al.
Publicado: (2014)